Search Results - narges+tafreshi

1 Results Sort By:
Breast Tumor Targeted Fluorescence Guidance for Intraoperative Margin Assessment
This technology is an anti-CEACAM6 antibody tagged with fluorescent labels. The idea is that these fluorescent antibodies can be used for real-time molecular fluorescence imaging to help guide the surgical removal of a tumor. This technology is targeted toward breast cancer. Background: Over half of the 270,000 breast cancer diagnoses in the United...
Published: 6/24/2024   |   Inventor(s): Daruka Mahadevan, David Morse, Marie Catherine Lee, Narges Tafreshi
Keywords(s):  
Category(s): Technology Classifications > Life Sciences > Diagnostics, Technology Classifications > Healthcare Portfolios > Oncology